Research Topics
Species | R Paul WadwaSummaryAffiliation: University of Colorado Health Sciences Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Awareness and treatment of dyslipidemia in young adults with type 1 diabetesR Paul Wadwa
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East 9th Ave, Box B140, Denver, CO 80262, USA
Diabetes Care 28:1051-6. 2005..In this report, we describe the prevalence of dyslipidemia and adequacy of pharmacological treatment in patients with type 1 diabetes and comparable nondiabetic subjects...
Noninvasive measures of cardiovascular changes in diabetes mellitusR Paul Wadwa
Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado 80045 6511, USA
Curr Opin Endocrinol Diabetes Obes 14:263-8. 2007..Such markers have gained popularity for research and clinical use. This paper reviews recent studies using noninvasive technology for detection and monitoring of cardiovascular disease as it pertains to diabetes patients...
Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetesR Paul Wadwa
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, 80045, USA
Int J Biochem Cell Biol 38:996-1003. 2006....
Cardiovascular disease risk in youth with diabetes mellitusR Paul Wadwa
Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, PO Box 6511, MS A140, 1775 N Ursula St, Aurora, CO 80045 6511, USA
Rev Endocr Metab Disord 7:197-204. 2006..Current roles of inflammatory markers and measures of subclinical vascular changes such as arterial stiffness are also discussed...
Age and sex influence cystatin C in adolescents with and without type 1 diabetesDavid M Maahs
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado, USA
Diabetes Care 34:2360-2. 2011..To compare serum cystatin C levels, a novel biomarker of renal function, in adolescents with and without type 1 diabetes and to determine what factors affect cystatin C levels...
ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcificationDavid M Maahs
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO, USA
J Diabetes Complications 21:273-9. 2007....
Determinants of serum adiponectin in persons with and without type 1 diabetesDavid M Maahs
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO 80045, USA
Am J Epidemiol 166:731-40. 2007..Although some of the difference can be explained, further study is needed to better understand the relation between elevated adiponectin levels and patient outcomes, including coronary heart disease...
Dyslipidemia in youth with diabetes: to treat or not to treat?David M Maahs
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO 80045, USA
J Pediatr 153:458-65. 2008
Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosisAdam Kretowski
Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, Mail Stop A140, P O Box 6511, Aurora, CO 80045 6511, USA
Diabetes 56:863-71. 2007....
Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control studyJohn Guy
Department of Epidemiology, Colorado School of Public Health, University of Colorado, Denver, Colorado, USA
Diabetes Care 32:416-20. 2009....
Longitudinal lipid screening and use of lipid-lowering medications in pediatric type 1 diabetesDavid M Maahs
Barbara Davis Center for Childhood Diabetes and the Department of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado 80045, USA
J Pediatr 150:146-50, 150.e1-2. 2007..Because cardiovascular disease (CVD) is the leading cause of death in patients with type 1 diabetes (T1D) and dyslipidemia is an important CVD risk factor, we investigated dyslipidemia and its treatment in children with T1D...
Hypoglycemia, diabetes, and cardiovascular diseaseJanet K Snell-Bergeon
Barbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Center, Aurora, Colorado 80045, USA
Diabetes Technol Ther 14:S51-8. 2012....
Measures of arterial stiffness in youth with type 1 and type 2 diabetes: the SEARCH for diabetes in youth studyR Paul Wadwa
Barbara Davis Center for Childhood Diabetes, University of Colorado School ofMedicine, Aurora, Colorado, USA
Diabetes Care 33:881-6. 2010..We identified factors associated with arterial stiffness in youth with diabetes and assessed the effects of these factors on the relationship between arterial stiffness and diabetes type (type 1 vs. type 2)...
Glucose control predicts 2-year change in lipid profile in youth with type 1 diabetesDavid M Maahs
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO, USA
J Pediatr 162:101-7.e1. 2013..To test the hypothesis that a change in glycated hemoglobin (A1c) over a follow-up interval of approximately 2 years would be associated with concomitant changes in fasting lipids in individuals with type 1 diabetes (T1D)...
Lessons learned from a lipid lowering trial in adolescents with type 1 diabetesFranziska K Bishop
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, 1775 Aurora Ct, Mail Stop F527, Aurora, CO, 80045, USA
Int J Pediatr Endocrinol 2012:24. 2012..Based on our experience, future studies will require multiple centers to enroll a sufficient number of participants for adequate data to direct dyslipidemia medication treatment guidelines for adolescents with type 1 diabetes...
Continuous glucose monitoring in youth with type 1 diabetesR Paul Wadwa
Barbara Davis Center for Childhood Diabetes, Aurora, Colorado 80045, USA
Diabetes Technol Ther 11:S83-91. 2009..In the future, CGM use in youth may couple with insulin pump technology to create a "closed-loop" system in which the CGM device will direct insulin administration without user input...
Oral Health Knowledge and Behaviors among Adolescents with Type 1 DiabetesValerie A Orlando
Department of Community and Behavioral Health, Colorado School of Public Health, University of Colorado Denver, Aurora, CO 80045, USA
Int J Dent 2010:942124. 2010..Significant opportunity exists for improving periodontal disease knowledge and adoption of preventive oral hygiene behaviors in adolescents with diabetes...
Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitusDavid M Maahs
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
J Pediatr 147:544-6. 2005..7%, 11.2%, and 16.3%, respectively, reported in the National Health and Nutrition Examination Survey 2001-02. Hemoglobin A1c value was significantly related to TC and non-HDL cholesterol levels...
Maternal risk factors for term neonatal seizures: population-based study in Colorado, 1989-2003Deborah A Hall
Department of Neurology, University of Colorado at Denver and Health Sciences Center, 4200 East Ninth Avenue, Denver, CO 80262, USA
J Child Neurol 21:795-8. 2006..Maternal diabetic vasculopathy can also be a contributing factor...
Beta-cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adultsDeborah A Elder
Cincinnati Children s Hospital Medical Center, Department of Pediatrics, Division of Endocrinology, Cincinnati, Ohio 45229, USA
J Clin Endocrinol Metab 91:185-91. 2006..Type 2 diabetes mellitus (T2DM) is estimated to account for 10-45% of incident pediatric diabetes cases...
Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth studyBeatriz L Rodriguez
Department of Geriatric Medicine, Pacific Health Research Institute, University of Hawaii at Manoa, Honolulu, USA
Diabetes Care 29:1891-6. 2006..Recommendations for weight, lipid, and blood pressure control in youth with diabetes need to be followed to prevent or delay the development of CVD as these youngsters mature...
